A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting Conor McCloskeyMaría Toboso OrtegaFederico Manevy Systematic Review Open access 23 August 2022 Pages: 3 - 36
Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial F. FelizziAino LaunonenP.-O. Thuresson Original Research Article Open access 28 July 2022 Pages: 37 - 46
Correction to: Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial F. FelizziAino LaunonenP.-O. Thuresson Correction Open access 12 September 2022 Pages: 47 - 48
Cost Effectiveness of Ambulatory Blood Pressure Monitoring Compared with Home or Clinic Blood Pressure Monitoring for Diagnosing Hypertension in Australia Karan K. ShahMelina WillsonRachael L. Morton Original Research Article Open access 19 September 2022 Pages: 49 - 62
Correction to: Cost Effectiveness of Ambulatory Blood Pressure Monitoring Compared with Home or Clinic Blood Pressure Monitoring for Diagnosing Hypertension in Australia Karan K. ShahMelina WillsonRachael L. Morton Correction Open access 31 October 2022 Pages: 63 - 63
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study Tetsuya MatsumotoAkira YuasaJason Gordon Original Research Article Open access 15 September 2022 Pages: 65 - 76
“Don’t Think Twice, It’s All Right”: Using Additional Data to Reduce Uncertainty Regarding Oncologic Drugs Provided Through Managed Access Agreements in England Jiyeon KangJohn Cairns Original Research Article Open access 20 September 2022 Pages: 77 - 91
Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis Mehdi JavanbakhtJesse FishmanAmir Ansaripour Original Research Article Open access 14 September 2022 Pages: 93 - 110
Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia Louisa G. GordonC. WoodOPAL Study Group Original Research Article Open access 17 October 2022 Pages: 111 - 120
Psychometric Validation of the Growth Hormone Deficiency–Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency–Parent Treatment Burden Measure (GHD-PTB) Meryl BrodMichael Højby RasmussenAristides Maniatis Original Research Article Open access 18 October 2022 Pages: 121 - 138
Mapping of the World Health Organization Quality of Life Brief (WHOQOL-BREF) to the EQ-5D-5L in the General Thai Population Krittaphas Kangwanrattanakul Original Research Article Open access 16 November 2022 Pages: 139 - 148
Mapping the Insomnia Severity Index Instrument to EQ-5D Health State Utilities: A United Kingdom Perspective François-Xavier ChaletTeodora BujaroskaAndrew H. Briggs Original Research Article Open access 26 January 2023 Pages: 149 - 161